Ratos: Notice of Annual General Meeting 16 April 2015 This

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Ratos: Notice of Annual General Meeting 16 April 2015

This information is disclosed in accordance with the Securities Markets Act, the Financial Instruments Trading Act or demands made in the exchange rules. Ratos's Annual General Meeting will be held on Thursday, 16 April at 16.30 CET at Stockholm Waterfront Congress Centre, Nils Ericsons Plan 4, Stockholm. The complete notice of the meeting is attached and available at www.ratos.se where attendance can also be notified. Complete AGM documentation will be available at Ratos's head office and on www.ratos.se from 6 March. Notice of attendance must be made to Ratos no later than 10 April. Board of Directors and auditors The Nomination Committee proposes Karsten Slotte to be elected as a new member of the Board. Lars Berg has declined re-election. The Nomination Committee further proposes re-election of Board members Staffan Bohman, Arne Karlsson, Annette Sadolin, Charlotte Strömberg, Jan Söderberg and Per-Olof Söderberg. Arne Karlsson is proposed as Chairman of the Board. A more detailed presentation of the proposed Board members and the work of the Nomination Committee is provided on the company's website www.ratos.se. The Nomination Committee further proposes re-election of PricewaterhouseCoopers AB as auditors for the period until the next Annual General Meeting has been held. Proposal for dividend on Class A and Class B shares The Board proposes an ordinary dividend of SEK 3.25 (3.00) per Class A and Class B share. The pro­posed record date for the dividend is 20 April and payment is expected to be made on 23 April 2015. Proposal for dividend on Class C preference shares The Board proposes that a dividend on outstanding Class C preference shares before the 2016 Annual General Meeting, in accordance with the Articles of Association, shall be paid quarterly in an amount of SEK 25 per Class C preference share, although a maximum of SEK 100. Proposed record dates for the quarterly dividends until the next Annual General Meeting are 15 May 2015, 14 August 2015, 13 November 2015 and 15 February 2016. Purchase of treasury shares The Board of Directors proposes that the Annual General Meeting gives the Board renewed authorisation, during the period until the next Annual General Meeting, on acquisition of a maximum number of shares so that the company's holding of treasury shares at any time does not exceed 7% of all the shares in the company. The purpose of the purchase of treasury shares is to give the Board more alternatives in its work to create value for the company's shareholders. Incentive programme The Board proposes that the Annual General Meeting resolves on an issue of a maximum of 800,000 call options on Class B Ratos treasury shares to be transferred at a market premium to key people at Ratos. The option purchases will be partly subsidised. It is further proposed that the Meeting decides on a transfer of a maximum of 800,000 Class B shares in the company when the options are exercised. In addition, the Board proposes, as in the previous year, that the Meeting resolves on a cash-based option programme related to Ratos's investments in the holdings. It is proposed that the programme is carried out through the issue of synthetic options which key people at Ratos will be entitled to acquire at a market price. The option purchases will be partly subsidised. The Board further proposes that the Meeting resolves on a transfer of a maximum of 16,000 Ratos Class B shares to administrative employees. Proposal for authorisation for new issue of Class B shares to be used for acquisitions The Board proposes that the Annual General Meeting, as in previous years, authorises the Board in conjunction with agreements on company acquisitions, on one or several occasions, with or without deviation from the pre-emptive rights of shareholders, for a cash payment, through set-off or non-cash, to make a decision on new issue of shares in the company. This authorisation shall comprise a maximum of 35 million Class B shares, which corresponds to 9.7% of the shares and 3.1% of voting rights (after full utilisation of the mandate) and applies until the next Annual General Meeting. Proposal for authorisation for a new issue of preference shares to be used for acquisitions The Board proposes that the Annual General Meeting resolves to authorise the Board in conjunction with agreements on company acquisitions, on one or several occasions, with or without deviation from the pre-emptive rights of shareholders, for a cash payment, through set-off or non-cash, to make a decision on new issue of Class C and/or Class D preference shares. The authorisation shall comprise a maximum total of 1,250,000 Class C and/or Class D preference shares and applies until the next Annual General Meeting. The Board has further proposed that the Annual General Meeting resolves on amendments to the Articles of Association to enable a new issue of Class D preference shares. The Board proposes that a dividend on Class C and/or Class D preference shares, which may be issued prior to the 2016 Annual General Meeting, shall be paid quarterly in an amount of SEK 25 per Class C and/or Class D preference shares, although a maximum of SEK 100. Shareholder proposal Shareholder Thorwald Arvidsson has submitted a proposal to the Annual General Meeting. Read more in the full Notice of the Annual General Meeting. For further information, please contact: Arne Karlsson, Chairman of the Board, Ratos, +46 8 700 17 00 Jan Andersson, Chairman of the Nomination Committee, +46 761 39 55 00 Appendix: Notice of the Annual General Meeting of Ratos AB (publ) 2015 Financial calendar from Ratos: Annual General Meeting 2015 16 April 2015 Interim report January-March 2015 7 May 2015 Interim report January-June 2015 14 August 2015 Interim report January-September 2015  6 November 2015 Ratos is a private equity conglomerate. The company's mission is to maximise shareholder value over time through the professional, active and responsible exercise of its ownership role in primarily unlisted medium sized Nordic companies. Ratos's holdings include AH Industries, Aibel, Arcus-Gruppen, Biolin Scientific, Bisnode, DIAB, Euromaint, GS-Hydro, Hafa Bathroom Group, HENT, HL Display, Inwido, Jøtul, KVD, Ledil, Mobile Climate Control, Nebula and Nordic Cinema Group. Ratos is listed on Nasdaq Stockholm and market capitalisation amounts to approximately SEK 20 billion. [HUG#1899538]

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading

Top 5 Most Recently Viewed Articles

Unlocking High Performance: WorkBoard's New AI Enhancements

Updated Category News Views 101

Back in 2024, WorkBoard turned heads with its ambitious AI enhancements designed to overhaul strategy execution. You remember how organizations were struggling to keep their objectives on track? Well, that was the backdrop when WorkBoard stepped in, hoping to redefine the game. AI Capabilities: A Game Changer or Just Hype? At the Accelerate conference that year, buzz...

Continue Reading
Strengthening Leadership for Enhanced AI-Powered Aesthetics

Updated Category News Views 380

Cloud Clinic Enhances Leadership for Future Growth Cloud Clinic, an innovative healthcare technology platform, is embarking on a significant journey to expand its leadership team. This decision comes as the company aims to accelerate its growth and improve patient care across the nation. Strategic Leadership Appointments Leading the charge is John Sandberg, the visionary...

Continue Reading
HKBU Advances Wastewater Treatment with Innovative Technology

Updated Category News Views 220

Transforming Wastewater Treatment with Innovative Membranes Recent advancements by a dedicated research team from Hong Kong Baptist University (HKBU) have led to the creation of a groundbreaking catalytic membrane. This novel technology significantly enhances the effectiveness of wastewater treatment processes using advanced oxidation methods. Such innovations are crucial...

Continue Reading
CleanCore Solutions Successfully Completes Significant Funding Round

Updated Category News Views 255

CleanCore Solutions Completes Major Private Placement Today, CleanCore Solutions, Inc. (NYSE American: ZONE) announced the successful closing of a significant private investment in public equity (PIPE) financing. This funding has raised an impressive $175,000,420, a noteworthy achievement prior to deducting any agent fees or related expenses, utilizing a mix of cash and...

Continue Reading
Understanding Western Alliance Bancorporation's Legal Challenges

Updated Category News Views 181

Background on Western Alliance Bancorporation Western Alliance Bancorporation is a prominent bank holding company, primarily engaged in various banking services. Recently, the firm has come under scrutiny due to allegations concerning misleading business information exchanged with investors. This situation compels attention from current and potential investors alike,...

Continue Reading